Index Ventures Forms New Life Sciences Investment Firm
Index Ventures' life science portfolio will now be housed by Medicxi Ventures, a newly formed venture capital firm that also closed a €210 million ($250 million) fund backed by GlaxoSmithKline and...To view the full article, register now.
Already a subscriber? Click here to view full article